Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients

Dialysis patient could be more aspirin resistant than the general population based on data from chronic kidney disease patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Aspirin Resistance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

We will try to describe the profile of aspirin resistant patient in hemodialysis patients

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all hemodialysis patients on aspirin

Exclusion criteria

low platelets <100.000
coagulopathy, bleeding disorders
patient on plavix

Treatment and study plan

Primary outcomes

Aspirin Resistance in Hemodialysis patients

Time frame: 2 months

Sponsors and collaborators

Lead sponsor

Northwell Health

Other

Collaborators

Staten Island University Hospital

Registry information

Official study title

Prevalence of Aspirin Resistance in Hemodialysis Patients

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Nov 17, 2008
Registry last updated: Jul 22, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed